Company Valuation: StemCell Institute Inc.

Data adjusted to current consolidation scope
Fiscal Period: March 2026 2027 2028
Market Cap 1 7,412 - -
Change - - -
Enterprise Value (EV) 5,352 7,412 7,412
Change - 0% 0%
P/E 49.6x 93.2x 21.8x
PBR 2.88x 2.45x 2.46x
PEG - -1.7x 0x
Capitalization / Revenue 2.74x 2.54x 2.15x
EV / Revenue 0x 2.54x 2.15x
EV / EBITDA 0x 27.5x 11.4x
EV / EBIT 0x 82.4x 16.5x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 15.44 7.9 33.8
Distribution rate - - -
Net sales 1 2,811 2,920 3,450
EBITDA 1 359.4 270 650
EBIT 1 202 90 450
Net income 1 155 80 340
Net Debt -2,362 - -
Reference price 2 736.00 736.00 736.00
Nbr of stocks (in thousands) 10,070 - -
Announcement Date 5/13/26 - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 48.57M
13.35x0.41x8.48x2.9% 117B
14.54x1.82x9.1x0.72% 93.19B
14.08x1.53x9.22x2.53% 29.99B
24.32x2.69x13.64x1.34% 27.27B
31.77x5.73x23.88x2.2% 21.49B
8.07x1.44x6.55x-.--% 21.4B
17.13x1.57x7.9x4.61% 15.81B
13.3x1.64x7.94x0.86% 12.36B
13.79x1x5.61x3.57% 12.24B
Average 16.71x 1.98x 10.26x 2.08% 35.11B
Weighted average by Cap. 15.57x 1.56x 9.79x 1.98%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 7096 Stock
  4. Valuation StemCell Institute Inc.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!